Clinical Trials on Advanced Malignancy in United Kingdom
Total 4997 results
-
Sue YomGenentech, Inc.CompletedSkin Cancer | Locally Advanced Basal Cell Carcinoma | Cutaneous MalignancyUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLC; Merck Serono GmbH, GermanyRecruitingNon Small Cell Lung Cancer | Advanced CancerUnited Kingdom
-
Oregon Health and Science UniversityRecruiting
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Clinical Stage III Gastric Cancer AJCC v8 | Clinical Stage IV Gastric Cancer AJCC v8 | Triple-Negative Breast Carcinoma and other conditionsUnited States, Canada
-
Abbott Medical DevicesThoratec Europe LtdCompletedAdvanced Heart Failure | CRT and/or ICDNetherlands, Sweden, Denmark, France, Germany, United Kingdom
-
Acacia Pharma LtdCompletedXerostomia in Advanced Cancer PatientsUnited Kingdom, Denmark
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLCActive, not recruiting
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustCompletedA Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread (NICAM)Mucosal Lentiginous Melanoma | Acral Lentiginous Malignant MelanomaUnited Kingdom
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedStage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid NeoplasmUnited States
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited Kingdom
-
Alison StopeckEli Lilly and Company; AstraZenecaWithdrawnLocally Advanced Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer FemaleUnited States
-
AmgenCompletedGlioblastoma Multiforme | Advanced Malignant Glioma | Anaplastic AstrocytomasUnited States, Australia
-
Cancer Research UKCompletedAdvanced Non-small Cell Lung CancerUnited Kingdom
-
Henry Ford Health SystemRecruitingMyeloid MalignancyUnited States
-
St. Jude Children's Research HospitalChildren's Hospital of Philadelphia; National Institute of Arthritis and Musculoskeletal...Active, not recruiting
-
Massachusetts General HospitalWithdrawn
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
National Cancer Institute (NCI)WithdrawnLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Aggressive Non-Hodgkin Lymphoma | Indolent Non-Hodgkin LymphomaUnited States
-
Sagimet Biosciences Inc.CompletedSolid Malignant TumorUnited Kingdom, United States
-
Astellas Pharma IncCompleted
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingLocally Advanced or Metastatic Malignant Solid TumorsUnited States, Japan, Canada
-
SCRI Development Innovations, LLCBayerCompletedRefractory MalignancyUnited States
-
University of MichiganWithdrawnGastrointestinal MalignancyUnited States
-
Mayo ClinicRecruitingMetastatic Lung Non-Small Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Resectable Lung Non-Small Cell Carcinoma | Metastatic Malignant Solid Neoplasm | Metastatic Bladder Urothelial Carcinoma | Metastatic Colorectal Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Locally... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Recurrent or Refractory Medulloblastoma | Locally Advanced or Metastatic Basal Cell CarcinomaUnited States, United Kingdom, Switzerland, Netherlands
-
SanofiCompletedNeoplasm MalignantNetherlands, Belgium, Spain, Italy, United Kingdom
-
Papworth Hospital NHS Foundation TrustCompletedMetastatic Cancer | Malignant MesotheliomaUnited Kingdom
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Novartis PharmaceuticalsCompleted
-
Astellas Pharma IncCompletedAdvanced Solid TumorsUnited States, United Kingdom
-
STORM Therapeutics LTDRecruitingCancer | Advanced Solid Tumor | Advanced CancerUnited States
-
ModernaTX, Inc.RecruitingAdvanced Solid TumorsUnited States, United Kingdom, Australia, Spain
-
University of South FloridaActive, not recruiting
-
National Cancer Institute (NCI)CompletedCancer | Childhood MalignancyUnited States
-
Cambridge University Hospitals NHS Foundation TrustBoehringer Ingelheim; Cancer Research UK; University of Cambridge; The Brain Tumour...TerminatedBreast Cancer | Advanced Breast Cancer | Lung Cancer | Brain Cancer | Advanced Lung CancerUnited Kingdom
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer (MBC) | Locally Advance Breast Cancer (LABC)United Kingdom, Spain
-
PfizerTerminatedAdvanced Solid Tumors | Advanced CancerUnited States
-
Astellas Pharma IncOSI PharmaceuticalsCompleted
-
PharmaMarCompletedAdvanced Solid TumorsSpain, United States, Belgium, France, Italy, Switzerland, Germany, Sweden, United Kingdom
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
Loma Linda UniversityCompletedGastric Cancer | Locally Advanced Malignant NeoplasmUnited States
-
Eli Lilly and CompanyTerminatedLymphoma | Advanced CancerUnited Kingdom
-
University of Alabama at BirminghamMerck Sharp & Dohme LLCCompleted
-
BiOneCure Therapeutics Inc.RecruitingCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
Guardant Health, Inc.CompletedNon-Hematologic MalignancyUnited States
-
Athanassios ArgirisUniversity of Pittsburgh; University of North Carolina, Chapel HillWithdrawnSalivary Gland MalignancyUnited States
-
University of LeicesterEli Lilly and Company; GlaxoSmithKline; Merck Sharp & Dohme LLC; Roche Pharma AG; British Lung Foundation and other collaboratorsActive, not recruitingMesothelioma, MalignantUnited Kingdom
-
Epizyme, Inc.RecruitingAdvanced Soft-tissue Sarcoma | Advanced Epithelioid SarcomaUnited States, Taiwan, Canada, United Kingdom
-
BayerActive, not recruitingAdvanced Solid TumorsUnited States, Singapore, Italy, United Kingdom
-
NuCana plcRecruitingMelanoma | Renal Cell Carcinoma | Gastric Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Advanced Cancer | Head and Neck Squamous Cell Carcinoma | Endometrial Carcinoma | Urothelial Carcinoma | Classical Hodgkin Lymphoma | Neoplasm Malignant | Pleural... and other conditionsUnited Kingdom